Discover 774 paid clinical trials in District of Columbia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 774
NSS Grocery Store Brazil
for
Control Group, Mexico-based NSS FOPL, Brazil-based NSS FOPL
Location: Washington D.C. DC
Sponsor: George Washington University
Sex: All
Age: 20+
Code: NCT07249008
Recruiting
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
for
Non-small Cell Lung Cancer (NSCLC)
Location: Boston MA, New York NY, Montreal, Washington D.C. DC,
Sponsor: Nuvation Bio Inc.
Sex: All
Age: 18+
Code: NCT07154706
Phase 3, Recruiting
Augmented Reality For MRI-Guided Interventions
for
Infections, Pain, Diagnosis
Location: Washington D.C. DC
Sponsor: Children's National Research Institute
Sex: All
Age: 3 - 21
Code: NCT06224933
Recruiting
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Boston MA, Worcester MA, New Haven CT, New York NY,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18+
Code: NCT07032662
Phase 2, Recruiting
Identifying Patterns in the Breath of Individuals With Breast Cancer
for
Breast Cancer
Location: Moncton, Washington D.C. DC, Durham NC, Jacksonville FL
Sponsor: Breathe BioMedical Inc
Sex: Female
Age: 40 - 70+
Code: NCT06512350
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months
for
Hypochondroplasia
Location: Baltimore MD, Washington D.C. DC, Chicago IL,
Sponsor: BioMarin Pharmaceutical
Sex: All
Age: 0 - 3
Code: NCT07126262
Phase 2, Recruiting
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
Location: New York NY, Philadelphia PA, Norfolk VA,
Sponsor: Allotera Therapeutics
Sex: All
Age: 0+
Code: NCT06514794
Phase 2, Recruiting
A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors
for
Solid Tumors
Location: New Brunswick NJ, Washington D.C. DC, Orlando FL,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT07123103
Phase 1, Recruiting
E-Mindfulness Approaches for Living After Breast Cancer
for
Breast Cancer, Depression
Location: Gloucester MA, Beverly MA, Peabody MA, Boston MA,
Sponsor: NRG Oncology
Sex: All
Age: 18 - 50
Code: NCT06748222
Phase 3, Recruiting
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
for
Transthyretin Amyloidosis With Cardiomyopathy
Location: Boston MA, Norwich CT, Manhasset NY, The Bronx NY,
Sponsor: Alnylam Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07052903
Phase 3, Recruiting
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
for
Generalized Myasthenia Gravis
Location: Foxborough MA, New Haven CT, New York NY, Totowa NJ,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18 - 70+
Code: NCT07039916
Phase 3, Recruiting
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
for
Acute Treatment of Migraine
Location: Port Jefferson Station NY, Philadelphia PA,
Sponsor: Pfizer
Sex: All
Age: 6 - 11
Code: NCT06995729
Phase 1, Recruiting
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
for
Prostate Cancer (Adenocarcinoma)
Location: Saint John, Providence RI, Saint Johnsbury VT,
Sponsor: Canadian Cancer Trials Group
Sex: Male
Age: 18+
Code: NCT06592924
Phase 3, Recruiting
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Location: Boston MA, New York NY, Washington D.C. DC, Fairfax VA,
Sponsor: Tango Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06922591
Phase 1, Phase 2, Recruiting
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
for
Recurrent Non-Muscle Invasive Bladder Carcinoma,
Location: Peabody MA, Boston MA, Burlington MA, Commack NY,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT07000084
Phase 3, Recruiting
Physiologic Measure of VIPN
for
Chemotherapy-induced Peripheral Neuropathy
Location: Washington D.C. DC
Sponsor: Children's National Research Institute
Sex: All
Age: 6 - 18
Code: NCT04786977
Recruiting
Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis
for
Sinus Infection, Acute Sinusitis
Location: Hershey PA, Washington D.C. DC, Richmond VA, Madison WI,
Sponsor: Daniel Merenstein
Sex: All
Age: 18 - 70+
Code: NCT06076304
Recruiting
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: St. John's, Bangor ME, Scarborough ME, Providence RI,